Synovics Pharmaceuticals Stock Net Income
| SYVC Stock | USD 0.0001 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Synovics Pharmaceuticals, as well as the relationship between them.
Synovics Pharmaceuticals Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.3837 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -3.6 M | -3.8 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Net Loss | (0.15) | (0.16) | |
| Net Income Per E B T | 1.02 | 0.89 |
Synovics | Net Income | Build AI portfolio with Synovics Stock |
Latest Synovics Pharmaceuticals' Net Income Growth Pattern
Below is the plot of the Net Income of Synovics Pharmaceuticals over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Synovics Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Synovics Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Synovics Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synovics Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (4.01 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Synovics Net Income Regression Statistics
| Arithmetic Mean | (3,904,921) | |
| Coefficient Of Variation | (7.11) | |
| Mean Deviation | 166,205 | |
| Median | (4,005,831) | |
| Standard Deviation | 277,712 | |
| Sample Variance | 77.1B | |
| Range | 1.1M | |
| R-Value | (0.19) | |
| Mean Square Error | 79.4B | |
| R-Squared | 0.03 | |
| Significance | 0.47 | |
| Slope | (10,269) | |
| Total Sum of Squares | 1.2T |
Synovics Net Income History
Other Fundumenentals of Synovics Pharmaceuticals
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Synovics Pharmaceuticals Net Income component correlations
Synovics Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Synovics Pharmaceuticals is extremely important. It helps to project a fair market value of Synovics Stock properly, considering its historical fundamentals such as Net Income. Since Synovics Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Synovics Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Synovics Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synovics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synovics Pharmaceuticals is measured differently than its book value, which is the value of Synovics that is recorded on the company's balance sheet. Investors also form their own opinion of Synovics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Synovics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synovics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Synovics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synovics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Synovics Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Synovics Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Synovics Pharmaceuticals.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Synovics Pharmaceuticals on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Synovics Pharmaceuticals or generate 0.0% return on investment in Synovics Pharmaceuticals over 90 days. Synovics Pharmaceuticals is related to or competes with Marti Technologies, TIM Participacoes, C4 Therapeutics, MicroCloud Hologram, Immersion, Horizon Technology, and Liberty Live. Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization... More
Synovics Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Synovics Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Synovics Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Synovics Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synovics Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Synovics Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Synovics Pharmaceuticals historical prices to predict the future Synovics Pharmaceuticals' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Synovics Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Synovics Pharmaceuticals Backtested Returns
We have found three technical indicators for Synovics Pharmaceuticals, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Synovics Pharmaceuticals are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Synovics Pharmaceuticals has perfect predictability. Overlapping area represents the amount of predictability between Synovics Pharmaceuticals time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Synovics Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current Synovics Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Synovics Operating Income
Operating Income |
|
Based on the recorded statements, Synovics Pharmaceuticals reported net income of (4.01 Million). This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Synovics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Synovics Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Synovics Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Synovics Pharmaceuticals by comparing valuation metrics of similar companies.Synovics Pharmaceuticals is currently under evaluation in net income category among its peers.
Synovics Fundamentals
| Return On Equity | -3.14 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (1.18) % | ||||
| Current Valuation | 894.82 K | ||||
| Shares Outstanding | 29.83 M | ||||
| Price To Sales | 0.03 X | ||||
| Revenue | 25.96 M | ||||
| Gross Profit | 4.47 M | ||||
| EBITDA | (3.64 M) | ||||
| Net Income | (4.01 M) | ||||
| Cash And Equivalents | 129.86 K | ||||
| Total Debt | 2.1 M | ||||
| Current Ratio | 0.27 X | ||||
| Book Value Per Share | (0.06) X | ||||
| Cash Flow From Operations | 3.86 M | ||||
| Number Of Employees | 155 | ||||
| Beta | 166.54 | ||||
| Market Capitalization | 542.86 K | ||||
| Total Asset | 22.35 M | ||||
| Retained Earnings | (78.65 M) | ||||
| Working Capital | (12.87 M) | ||||
| Current Asset | 4.68 M | ||||
| Current Liabilities | 17.55 M | ||||
| Net Asset | 22.35 M |
About Synovics Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synovics Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synovics Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synovics Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Synovics Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synovics Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synovics Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synovics Pharmaceuticals Stock:Check out Synovics Pharmaceuticals Piotroski F Score and Synovics Pharmaceuticals Altman Z Score analysis. For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synovics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synovics Pharmaceuticals is measured differently than its book value, which is the value of Synovics that is recorded on the company's balance sheet. Investors also form their own opinion of Synovics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Synovics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synovics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Synovics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synovics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.